Clinical variables | Number of cases | MYLK-AS1 expression | P value | |
---|---|---|---|---|
Low N = 78 |
High N = 78 | |||
Age (years) | ||||
> 50 | 26 | 15 | 11 | 0.390 |
≤ 50 | 130 | 63 | 67 | |
Gender | ||||
Male | 103 | 48 | 55 | 0.237 |
Female | 53 | 30 | 23 | |
Tumor number | ||||
Single | 125 | 65 | 60 | 0.316 |
Multiple | 31 | 13 | 18 | |
Etiology | ||||
viral | 122 | 58 | 64 | |
Non-viral | 34 | 20 | 14 | 0.245 |
Serum AFP (ng/ml) | ||||
≤ 200 | 75 | 33 | 42 | 0.149 |
> 200 | 81 | 45 | 36 | |
Tumor stage | ||||
I/II | 85 | 52 | 33 | 0.002 |
III/IV | 71 | 26 | 45 | |
Tumor size (cm) | ||||
≤ 5 | 62 | 41 | 21 | 0.001 |
> 5 | 94 | 37 | 57 | |
Tumor differentiation | ||||
Well | 58 | 37 | 21 | 0.018 |
Moderate | 49 | 23 | 26 | |
Poor | 49 | 18 | 31 | |
Vascular invasion | ||||
Yes | 50 | 19 | 31 | 0.040 |
No | 106 | 59 | 47 | |
TACE treatment | ||||
Yes | 72 | 28 | 44 | 0.010 |
No | 84 | 50 | 34 |